Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Cell Reports. Medicine
|
May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Xiqi Li, Qi Wang, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
Hussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Clinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Cell Reports
|
April 21, 2021
Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity
Neus Bota-Rabassedas, Priyam Banerjee, Yichi Niu, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Cell Reports. Medicine
|
May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Xiqi Li, Qi Wang, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
Hussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Clinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Cell Reports
|
April 21, 2021
Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity
Neus Bota-Rabassedas, Priyam Banerjee, Yichi Niu, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Nature Communications
|
July 7, 2019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu, Junya Fujimoto, Lisha Ying, et al.
Nature Communications
|
November 18, 2021
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Ming Chen, Runzhe Chen, Ying Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Cancer Cell
|
May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception
Bo Zhu, Pingjun Chen, Muhammad Aminu, et al.
Page
of 12